A patient with type 2 diabetes presents with increased numbness and tingling in her feet, decreased sensation on monofilament testing, early signs of diabetic retinopathy, and laboratory findings of poor glycemic control and early-stage nephropathy. Which nursing intervention is most appropriate to address the risk of foot complications in this patient?

A) Educate the patient on daily foot inspection and proper footwear.

B) Recommend reduction of physical activity to prevent foot injuries.

C) Advise the patient to apply topical corticosteroids to reduce inflammation.

D) Suggest the use of heating pads to improve circulation in the feet.

A patient with a history of type 2 diabetes presents with increased numbness and tingling in her feet, decreased sensation on the monofilament test, and a hemoglobin A1c of 9.2%. Which nursing intervention should be prioritized to address the patient's current needs and prevent complications?

A) Educate the patient on daily foot care and the importance of regular inspection to prevent injury.

B) Suggest the patient increase physical activity to improve circulation and sensation in the feet.

C) Advise the patient to monitor blood glucose levels twice a day to achieve better glycemic control.

D) Recommend the patient start a low-carbohydrate diet to help lower her hemoglobin A1c level.

A patient with type 2 diabetes mellitus has been started on a GLP-1 receptor agonist and reports a significant reduction in appetite and weight loss. However, the patient continues to experience numbness and tingling in her feet. Which nursing intervention is most appropriate to address the patient's ongoing concerns about diabetic neuropathy?

B) Educate the patient on daily foot care practices to prevent complications from neuropathy.

A) Increase the dosage of the GLP-1 receptor agonist to further improve glycemic control.

B) Educate the patient on daily foot care practices to prevent complications from neuropathy.

C) Advise the patient to discontinue the GLP-1 receptor agonist due to the side effects of numbness and tingling.

D) Recommend the addition of a neuropathic pain medication to the treatment plan.

During a follow-up appointment, a patient with type 2 diabetes reports adhering to a revised medication regimen that includes a GLP-1 receptor agonist. Despite improvements in appetite and weight loss, the patient continues to experience numbness and tingling in her feet. Which nursing intervention should be prioritized to address the ongoing concern of diabetic neuropathy?

B) Educate the patient on the importance of regular podiatric assessments

A) Increase the dosage of the GLP-1 receptor agonist to enhance glycemic control

B) Educate the patient on the importance of regular podiatric assessments

C) Recommend discontinuation of the GLP-1 receptor agonist due to side effects

D) Suggest the addition of a statin to address elevated LDL cholesterol levels

A patient with type 2 diabetes presents with increased fatigue, occasional dizziness, and a slight increase in blood pressure. Despite adherence to lifestyle modifications, her LDL cholesterol remains elevated, and recent labs indicate a slight decline in renal function. Which nursing action is most appropriate to prioritize at this time?

B) Collaborate with the healthcare provider to consider starting a statin medication

A) Encourage the patient to increase physical activity to further lower LDL cholesterol

B) Collaborate with the healthcare provider to consider starting a statin medication

C) Advise the patient to reduce sodium intake to help manage blood pressure

D) Educate the patient on the importance of regular blood glucose monitoring to prevent further complications

A patient with type 2 diabetes presents with increased fatigue, occasional dizziness, and a slight rise in blood pressure. Her lab results show a decrease in hemoglobin A1c to 7.9% but an increase in serum creatinine to 1.3 mg/dL and a decrease in eGFR to 58 mL/min/1.73 m², indicating early decline in kidney function. Which of the following nursing interventions is most appropriate to address the potential progression of nephropathy in this patient?

B) Discuss the importance of maintaining a low-sodium diet to manage blood pressure.

A) Encourage the patient to increase fluid intake to promote kidney function.

B) Discuss the importance of maintaining a low-sodium diet to manage blood pressure.

C) Advise the patient to reduce physical activity to prevent further fatigue.

D) Recommend discontinuation of antihypertensive medication to improve renal perfusion.

A patient with diabetic nephropathy presents with increased lower extremity edema, mild shortness of breath, and rising blood pressure. The patient's serum creatinine has increased, and eGFR has declined. With the serum potassium at the upper limit of normal, what is the most appropriate nursing action to prioritize at this time?

B) Discuss with the healthcare provider the potential adjustment of the antihypertensive regimen to include a diuretic.

A) Educate the patient about increasing fluid intake to flush out excess potassium.

B) Discuss with the healthcare provider the potential adjustment of the antihypertensive regimen to include a diuretic.

C) Suggest the patient discontinue the ACE inhibitor to prevent hyperkalemia.

D) Recommend increasing dietary potassium intake to maintain electrolyte balance.

A patient with progressive renal impairment and a recent switch from an ACE inhibitor to an ARB is being monitored. What is the most appropriate nursing action if the patient reports increased fatigue and persistent bilateral pitting edema despite these medication changes?

B) Educate the patient about reducing dietary potassium intake.

A) Advise the patient to increase fluid intake to reduce edema.

B) Educate the patient about reducing dietary potassium intake.

C) Suggest the patient increase physical activity to alleviate fatigue.

D) Recommend the patient take an over-the-counter diuretic.

A patient with progressive renal impairment and a history of hypertension has been transitioned from an ACE inhibitor to an ARB due to elevated potassium levels. A low-dose loop diuretic has also been initiated. Which of the following nursing interventions is most appropriate to prevent complications related to this new medication regimen?

C) Advise the patient to avoid salt substitutes that contain potassium to prevent hyperkalemia.

A) Encourage the patient to increase dietary potassium intake to counteract potential hypokalemia.

B) Monitor the patient for signs of dehydration and electrolyte imbalances, such as confusion or muscle cramps.

C) Advise the patient to avoid salt substitutes that contain potassium to prevent hyperkalemia.

D) Instruct the patient to take the loop diuretic at bedtime to enhance diuresis during sleep.

diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: In type 1 diabetes, autoimmune destruction of pancreatic beta cells leads to insufficient insulin production, resulting in elevated blood glucose levels.

• Secondary mechanism: In type 2 diabetes, insulin resistance occurs, where body cells fail to respond effectively to insulin, often combined with inadequate insulin secretion by the pancreas.

• Key complication: Chronic hyperglycemia can cause damage to blood vessels and nerves, leading to complications such as neuropathy, nephropathy, and retinopathy, significantly impacting patient quality of life and increasing the risk of cardiovascular disease.

Patient Profile

Demographics:

52-year-old female, school teacher

History:

• Key past medical history: Type 2 Diabetes diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 20 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent fatigue and tingling in feet

• Key symptoms: Increased thirst, frequent urination, blurred vision, numbness in extremities

• Vital signs: Blood pressure 150/90 mmHg, Heart rate 88 bpm, Respiratory rate 18 breaths/min, Temperature 98.6°F, Blood glucose 210 mg/dL

Section 1

Following the initial presentation, the healthcare team conducted a comprehensive assessment to better understand the patient's condition. During the physical examination, the patient reported increased numbness and tingling in her feet, which raised concerns about the progression of diabetic peripheral neuropathy. The monofilament test revealed decreased sensation in both feet, particularly in the toes and soles, suggesting significant sensory neuropathy. Additionally, a fundoscopic examination was performed, revealing early signs of diabetic retinopathy characterized by microaneurysms and small hemorrhages in the retina.

Laboratory tests were ordered to evaluate the patient's overall metabolic control and assess potential complications. The hemoglobin A1c level came back at 9.2%, indicating poor long-term glycemic control. Serum creatinine and estimated glomerular filtration rate (eGFR) were also evaluated, with results showing a creatinine level of 1.4 mg/dL and an eGFR of 55 mL/min/1.73 m², suggesting early-stage diabetic nephropathy. Lipid profile testing revealed an LDL cholesterol level of 145 mg/dL, highlighting the need for more aggressive management of her hyperlipidemia to mitigate cardiovascular risk.

These findings prompted a multidisciplinary approach to refine the patient's management plan. The primary care provider considered optimizing her diabetes regimen by potentially adding a GLP-1 receptor agonist or SGLT2 inhibitor to improve glycemic control and address cardiovascular risk. A referral to a podiatrist was recommended for further evaluation of her foot care, and an ophthalmology appointment was advised to monitor and manage her retinopathy. These interventions underscored the importance of comprehensive care in preventing further complications and improving the patient's quality of life.

Section 2

Following the implementation of the updated management plan, the patient returned for a follow-up appointment six weeks later. During this visit, the healthcare team focused on evaluating the patient's response to the interventions. The patient reported adhering to her revised medication regimen, which now included a GLP-1 receptor agonist. She noted a significant reduction in her appetite and had lost five pounds, which she attributed to dietary modifications and increased physical activity. However, she continued to experience numbness and tingling in her feet, with occasional sharp pains, which raised ongoing concerns about her diabetic neuropathy.

Vital signs were taken and showed a slight improvement, with a blood pressure reading of 130/78 mmHg and a heart rate of 76 beats per minute. Repeat laboratory tests were conducted to assess her metabolic control. The hemoglobin A1c had decreased to 8.4%, indicating some improvement in glycemic control, though it remained above the target goal. Additionally, her serum creatinine and eGFR remained stable, suggesting no further progression of nephropathy at this time. The lipid profile showed an LDL cholesterol level of 135 mg/dL, reflecting a modest improvement but still necessitating further action to achieve optimal cardiovascular risk reduction.

The healthcare team discussed the importance of continued lifestyle modifications, including dietary adjustments and regular exercise, to enhance the patient's overall health outcomes. The patient was educated about the potential side effects of her new medication and was advised to report any significant changes in her symptoms or new concerns promptly. The team also emphasized the necessity of follow-up appointments with the podiatrist and ophthalmologist to monitor her neuropathy and retinopathy, respectively. With these steps in place, the patient left the appointment with a clearer understanding of her condition and the necessary actions to take to prevent further complications, setting the stage for the next phase of her treatment journey.

Section 3

As the patient continued on her treatment plan, she returned for another follow-up appointment three months later, presenting with new symptoms that warranted careful evaluation. She reported experiencing increased fatigue and occasional dizziness, which had become more pronounced in the past few weeks. Despite her efforts to maintain dietary changes and regular exercise, she noted a plateau in her weight loss efforts. During the assessment, her blood pressure was recorded at 140/86 mmHg, indicating a slight rise, and her heart rate was 82 beats per minute. The healthcare team noted that while her blood pressure was still within a manageable range, the upward trend required attention.

Laboratory tests revealed her hemoglobin A1c had decreased further to 7.9%, demonstrating continued improvement in glycemic control but still above the optimal target. However, new concerns emerged with her renal function tests, as her serum creatinine had increased slightly to 1.3 mg/dL, and her eGFR dropped to 58 mL/min/1.73 m², suggesting a potential early decline in kidney function. Additionally, her LDL cholesterol remained elevated at 130 mg/dL, despite following dietary recommendations and medication adherence.

The healthcare team considered the possibility of further complications arising from her diabetic condition, including the progression of nephropathy. They engaged in clinical reasoning to assess the potential need for adjustments in her antihypertensive regimen and discussed the potential benefits of adding a statin to better manage her lipid levels. The team emphasized the importance of closely monitoring her kidney function and blood pressure to prevent further renal damage. They also reinforced the need for regular follow-up appointments and consistent communication regarding any new symptoms. With these considerations, the patient was encouraged to maintain her current lifestyle modifications while awaiting the next phase of her treatment plan, which included a nephrology referral for further evaluation and management.

Section 4

Three weeks after her nephrology referral, the patient returned for a follow-up visit, presenting with new symptoms of persistent lower extremity edema and mild shortness of breath. These symptoms had developed gradually, raising concerns about potential fluid retention and cardiovascular stress. During the physical examination, pitting edema was noted in her ankles bilaterally. Her blood pressure had risen further to 148/90 mmHg, and her heart rate was slightly elevated at 88 beats per minute. The healthcare team recognized these changes as indicative of worsening volume overload and possible progression of diabetic nephropathy.

Additional laboratory tests were ordered to further investigate her renal function and electrolyte balance. The results showed a further slight increase in serum creatinine to 1.5 mg/dL, and her eGFR had declined to 54 mL/min/1.73 m², confirming continued deterioration of kidney function. Her serum potassium level was at the upper limit of normal at 5.0 mEq/L, necessitating close monitoring given the risk of hyperkalemia, especially with her current antihypertensive regimen, which included an ACE inhibitor. In response to these findings, the healthcare team discussed the potential need to adjust her medication to better manage her blood pressure and protect her renal function. They considered the addition of a diuretic to address the edema and discussed the possibility of switching to an angiotensin receptor blocker (ARB) if her potassium levels continued to rise.

The patient was advised to monitor her blood pressure at home regularly and report any further changes in symptoms promptly. The team emphasized the importance of dietary sodium restriction to help manage her edema and blood pressure. They also reinforced the importance of keeping her follow-up appointment with the nephrologist to ensure comprehensive management of her renal health. With these adjustments, the healthcare team aimed to stabilize her condition and prevent further complications, setting the stage for the next steps in her ongoing care plan.

Section 5

Several weeks later, the patient returned to the clinic for a scheduled follow-up. During the visit, she reported feeling more fatigued than usual and experiencing increased episodes of blurred vision. She also mentioned experiencing occasional palpitations, especially after meals. Upon examination, the healthcare team noted persistent bilateral pitting edema in her lower extremities, which had now extended to her calves. Her blood pressure was slightly elevated at 150/92 mmHg, and her heart rate had increased to 92 beats per minute, indicating potential cardiovascular strain. Her weight had also increased by 3 kg since the last visit, suggesting ongoing fluid retention despite her efforts to adhere to dietary sodium restrictions.

In light of these developments, additional laboratory tests were conducted to reassess her electrolyte balance and renal function. The results revealed a serum creatinine level of 1.6 mg/dL and a further decline in eGFR to 50 mL/min/1.73 m², suggesting progressive renal impairment. Notably, her serum potassium level had risen to 5.3 mEq/L, raising concerns about the continued use of her ACE inhibitor. Given the elevated potassium levels and the patient's symptoms, the healthcare team decided to transition her from the ACE inhibitor to an ARB, anticipating better potassium management. They also initiated a low-dose loop diuretic to help alleviate her edema and manage fluid overload more effectively.

These changes in her medication regimen were explained to the patient, emphasizing the importance of monitoring for any side effects or changes in symptoms. The healthcare team reinforced the need for regular blood pressure and weight monitoring at home, as well as adherence to follow-up appointments for close monitoring of her renal function and cardiovascular status. The patient was reminded to seek immediate medical attention if she experienced any signs of worsening heart failure, such as increased shortness of breath or rapid weight gain. With these adjustments, the healthcare team aimed to mitigate the risks of further complications and stabilize her condition, setting the stage for ongoing management of her diabetes and its complications.